Together we will beat cancer


New targeted lung cancer screening programme on the horizon

Today, the UK National Screening Committee has recommended introducing a targeted lung cancer screening programme across the UK, for those…

Read More

Banking on breakthroughs for children and young people

A newly merged biobank will be UK’s leading biomedical research resource dedicated to storing samples and data of cancers in children and young people – we explore its potential impact…

Read More

Looking back at a life-changing clinical trial

In an unusual turn of events, the results of a clinical trial for mitoxantrone turned out to be so effective that the randomisation of the trial was halted early. 

Read More

NICE doesn’t recommend olaparib for patients with certain prostate cancers

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

Read More

From smart knives to virtual reality tumours: five innovations in understanding cancer

This entry is part 6 of 6 in the series Cancer Revolutionaries

We dive into five innovations from the world’s greatest minds that could transform the way we deal with cancer

Read More

Help seeking: Why isn’t it as simple as it might sound?

A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it?

Read More

Closing the gap: How new screening interventions could reduce inequalities in bowel cancer outcomes

When it comes to diagnosing cancers early, screening is our best available tool. Cancer screening involves testing for early signs…

Read More

‘Normal’ cells and ‘cancer’s surprising circular DNA’: Inside Cancer Grand Challenges Part 2

This entry is part 2 of 2 in the series Inside Cancer Grand Challenges

We’re unpacking two recently funded Cancer Grand Challenges, and introducing the global, multidisciplinary teams taking them on.

Read More

How erectile dysfunction drugs could be the key to overcoming treatment resistance in oesophageal cancer

Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect. 

Read More

Why haven’t we cured cancer?

This entry is part 4 of 6 in the series Cancer Revolutionaries

Despite big improvements in survival, cancer is still one of the world’s biggest killers. Leading scientists explain why it presents such a challenge – and look at how far we’ve come

Read More